­
­
­
­

Inventi Impact: Medicine

Articles

  • Inventi:hmc/31665/20
    Impact of Baseline LDL-C and Lp(a) Elevation on Coronary Revascularization in Patients with Acute Coronary Syndrome One-Year After First Percutaneous Coronary Intervention
    Research 2020 : July - September
    Qarqeen A Hameed, Lijuan Chen, Mingming Yang, Jawad Afzali, Genshan Ma

    Objective: The aim of this study was to investigate the effect of Lipoprotein-a\n[Lp(a)] on Coronary Revascularizaton (CR) on one year follow up in patients\nwith Acute Coronary Syndrome (ACS) after the first Percutaneous Coronary\nIntervention (PCI). Method: A retrospective study was designed. A total of\n475 patients that underwent their first PCI treatment due to ACS between\nJanuary 2016 and December 2017 were recruited and followed for one year at\nthe Zhongda Hospital, China. The clinical end point after first PCI was prevalence\nof Major Adverse Cardiovascular Events (MACE) including nonfatal\nMyocardial Infarction (MI), cardiovascular death, ischemic stroke and Coronary\nRevascularization (CR). According to the cut point of Lp(a), participants\nwere divided into low Lp(a) subgroup (Lp(a) < 300 mg/L) and high Lp(a).....................

    How to Cite this Article
    Attribution/ CC Compliant Citation: Hameed, Q.A., Chen, L.J., Yang, M.M., Afzali, J. and Ma, G.S. (2020) Impact of Baseline LDL-C and Lp(a)\nElevation on Coronary Revascularization in Patients with Acute Coronary Syndrome One-Year after First Percutaneous\nCoronary Intervention. World Journal of Cardiovascular Diseases, 10, 102-115.\nhttps://doi.org/10.4236/wjcd.2020.102012\nhttp://creativecommons.org/licenses/by/4.0/\n\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article
    Download Full Text